Recipient of federal assistance · BOSTON, MA

AXONIS THERAPEUTICS, INC.

AXONIS THERAPEUTICS, INC. received $0 in federal grants and other assistance in FY2026, on 3 actions. It has no federal contracts in the loaded years. Since FY2022: $3.6M.

Assistance · FY2026
$0
New awards
0
Actions
3
Since FY2022
$3.6M
UEI
LR1MVZHCSJ95
Location
BOSTON, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.7MFY2022
  2. 1.7MFY2023
  3. 323KFY2024
  4. -206.4KFY2025
  5. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. DEVELOPMENT OF ORAL KCC2 POTENTIATOR AXN-027 AS A NOVEL ANTI-EPILEPTIC DRUG FOR MESIAL TEMPORAL LOBE EPILEPSY - DEVELOPMENT OF ORAL KCC2…$323K
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Aug 28, 2024 – Mar 2, 2026· R43NS137942
  2. ACCELERATING TRANSLATION OF A SMALL-MOLECULE KCC2 ENHANCER TO PROMOTE RECOVERY AND REDUCE NEUROPATHIC PAIN AFTER SCI USING A PIG MODEL$316.1K
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Sep 16, 2022 – Oct 29, 2025· W81XWH2210923
  3. DEVELOPMENT OF ORAL KCC2 ENHANCER DRUG FOR TREATMENT OF PAINFUL DIABETIC NEUROPATHY - DEVELOPMENT OF ORAL KCC2 ENHANCER DRUG FOR TREATMENT…$299.8K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jun 15, 2023 – Jan 5, 2026· R43DK135194

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.